The China pharmaceutical contract packaging market is expected to exhibit a CAGR of 9.95% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Contract packaging refers to hiring a company on a contractual basis to fulfil packaging needs. It includes primary and secondary packaging of final products and distribution of the product directly to the customer. Outsourcing plays a significant role in the pharmaceutical industry as it helps them focus on their core capabilities. Numerous benefits associated with outsourcing packaging processes across the pharmaceutical sector include cost reduction, effective inventory management, superior packaging, customization, and time efficiency. Contract packaging companies also offer smart packaging solutions to protect drugs from heat and other external factors.
Pharmaceutical Contract Packaging Market Trends:
The market in China is primarily driven by the lack of resources and packaging expertise across small to medium-sized pharmaceutical companies. This, in turn, is stimulating the demand for contract packaging solutions across the country. Furthermore, various stringent rules imposed by the government regarding the packaging of drugs are positively influencing the market. Moreover, numerous contract packagers are heavily investing in upgrading their technology to extend the life span of the equipment, thereby providing an impetus to the market. Besides this, these contract companies are increasingly deploying efficient and highly automated packaging equipment for faster output, which is strengthening the market growth across the region. Other factors, including the escalating integration with advanced technologies, the growing expenditure on research and development (R&D) activities, and high competition in the pharmaceutical industry, are anticipated to propel the demand for these services in the future.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the China pharmaceutical contract packaging market, along with forecasts at the country and regional level from 2022-2027. Our report has categorized the market based on industry, type and packaging.
Breakup by Industry:
- Small Molecule
Breakup by Type:
Breakup by Packaging:
- Plastic Bottles
- Caps and Closures
- Blister Packs
- Prefilled Syringes
- Parenteral Vials and Ampoules
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
|Base Year of the Analysis
| Historical Period
||Industry, Type, Packaging, Region
||Guangdong, Jiangsu, Shandong, Zhejiang, Henan
||10% Free Customization
|Report Price and Purchase Option
||Single User License: US$ 2699
Five User License: US$ 3699
Corporate License: US$ 4699
|Post-Sale Analyst Support
||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)
Key Questions Answered in This Report:
- How has the China pharmaceutical contract packaging market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the China pharmaceutical contract packaging market?
- What are the key regional markets?
- What is the breakup of the market based on the industry?
- What is the breakup of the market based on the type?
- What is the breakup of the market based on the packaging?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the China pharmaceutical contract packaging market and who are the key players?
- What is the degree of competition in the industry?